De La Rosa Abel - Net Worth and Insider Trading
De La Rosa Abel Net Worth
The estimated net worth of De La Rosa Abel is at least $873 dollars as of 2024-06-01. De La Rosa Abel is the Director of Virios Therapeutics Inc and owns about 4,000 shares of Virios Therapeutics Inc (VIRI) stock worth over $873. Details can be seen in De La Rosa Abel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that De La Rosa Abel has not made any transactions after 2022-01-07 and currently still holds the listed stock(s).
Transaction Summary of De La Rosa Abel
De La Rosa Abel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, De La Rosa Abel owns 1 companies in total, including Virios Therapeutics Inc (VIRI) .
Click here to see the complete history of De La Rosa Abel’s form 4 insider trades.
Insider Ownership Summary of De La Rosa Abel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VIRI | Virios Therapeutics Inc | 2022-01-07 | director |
De La Rosa Abel Latest Holdings Summary
De La Rosa Abel currently owns a total of 1 stock. De La Rosa Abel owns 4,000 shares of Virios Therapeutics Inc (VIRI) as of January 7, 2022, with a value of $873.
Latest Holdings of De La Rosa Abel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VIRI | Virios Therapeutics Inc | 2022-01-07 | 4,000 | 0.22 | 873 |
Holding Weightings of De La Rosa Abel
De La Rosa Abel Form 4 Trading Tracker
According to the SEC Form 4 filings, De La Rosa Abel has made a total of 1 transactions in Virios Therapeutics Inc (VIRI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Virios Therapeutics Inc is the acquisition of 4,000 shares on January 7, 2022, which cost De La Rosa Abel around $23,600.
Insider Trading History of De La Rosa Abel
- 1
De La Rosa Abel Trading Performance
GuruFocus tracks the stock performance after each of De La Rosa Abel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by De La Rosa Abel is -20.07%. GuruFocus also compares De La Rosa Abel's trading performance to market benchmark return within the same time period. The performance of stocks bought by De La Rosa Abel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how De La Rosa Abel's insider trading performs compared to the benchmark.
Performance of De La Rosa Abel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.97 | | | | | |
| Relative Return to S&P 500(%) | 17.1 | | | | | |
De La Rosa Abel Ownership Network
De La Rosa Abel Owned Company Details
What does Virios Therapeutics Inc do?
Who are the key executives at Virios Therapeutics Inc?
De La Rosa Abel is the director of Virios Therapeutics Inc. Other key executives at Virios Therapeutics Inc include director & Chief Executive Officer Gregory Scott Duncan , VP of Finance Angela Walsh , and Vice President of Operations Ralph Grosswald .
Virios Therapeutics Inc (VIRI) Insider Trades Summary
Over the past 18 months, De La Rosa Abel made no insider transaction in Virios Therapeutics Inc (VIRI). Other recent insider transactions involving Virios Therapeutics Inc (VIRI) include a net purchase of 25,000 shares made by Gregory Scott Duncan , a net purchase of 15,335 shares made by William Pridgen , and a net sale of 1,800 shares made by Richard James Whitley .
In summary, during the past 3 months, insiders sold 0 shares of Virios Therapeutics Inc (VIRI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,800 shares of Virios Therapeutics Inc (VIRI) were sold and 40,335 shares were bought by its insiders, resulting in a net purchase of 38,535 shares.
Virios Therapeutics Inc (VIRI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Virios Therapeutics Inc Insider Transactions
De La Rosa Abel Mailing Address
Above is the net worth, insider trading, and ownership report for De La Rosa Abel. You might contact De La Rosa Abel via mailing address: 44 Milton Avenue, Alpharetta Ga 30009.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
